PEDRO BILBAO ZULAICA-rekin lankidetzan egindako argitalpenak (13)

2006

  1. Cytomodulation of interleukin-2 effect by L-2-oxothiazolidine-4-carboxylate on human malignant melanoma

    Cancer Immunology, Immunotherapy, Vol. 55, Núm. 8, pp. 948-957

  2. Influence of the level of γ-glutamyltranspeptidase activity on the response of poorly and moderately differentiated rhabdomyosarcoma cell lines to all-trans-retinoic acid

    Anti-Cancer Drugs, Vol. 17, Núm. 10, pp. 1127-1139

2002

  1. L-2-oxothiazolidine-4-carboxylate reverses the tumour growth-promoting effect of interleukin-2 and improves the anti-tumour efficacy of biochemotherapy in mice bearing B16 melanoma liver metastases

    Melanoma Research, Vol. 12, Núm. 1, pp. 17-26

  2. Role of γ-glutamyltranspeptidase on the response of poorly and moderately differentiated rhabdomyosarcoma cell lines to buthionine sulfoximine-induced inhibition of glutathione synthesis

    Anti-Cancer Drugs, Vol. 13, Núm. 3, pp. 281-291

2000

  1. Effects of L-2-oxothiazolidine-4-carboxylate on the cytotoxic activity and toxicity of cyclophosphamide in mice bearing B16F10 melanoma liver metastases

    Melanoma Research, Vol. 10, Núm. 2, pp. 103-112

  2. Tunicamycin treatment reduces intracellular glutathione levels: Effect on the metastatic potential of the rhabdomyosarcoma cell line S4MH

    Chemotherapy, Vol. 46, Núm. 6, pp. 408-428

1999

  1. In vitro and in vivo comparison between the effects of treatment with adenosine triphosphate and treatment with buthionine sulfoximine on chemosensitization and tumour growth of B16 melanoma

    Melanoma Research, Vol. 9, Núm. 3, pp. 233-242

1997

  1. Interleukin-2 increases intracellular glutathione levels and reverses the growth inhibiting effects of cyclophosphamide on B16 melanoma cells

    Clinical and Experimental Metastasis, Vol. 15, Núm. 3, pp. 329-337

1996

  1. HOX genes and cell adhesion molecules in cancers.

    The International journal of developmental biology, Vol. Suppl 1

  2. Tumor-host interaction in non-random metastatic pattern distribution

    Bulletin du Cancer, Vol. 83, Núm. 1, pp. 27-38

1995

  1. The addition of interleukin-2 to cyclophosphamide therapy can facilitate tumor growth of B16 melanoma

    Cancer Immunology Immunotherapy, Vol. 40, Núm. 5, pp. 292-298

1994

  1. LA ADICION DE INTERLEUCINA 2 AL TRATAMIENTO CON CICLOFOSFAMIDA DISMINUYE LA SUPERVIVENCIA DE LOS ANIMALES CON METASTASIS DEL MELANOMA. ESTUDIO IN VIVO CON EL MELANOMA B16

    Oncologia, Vol. 17, Núm. 4, pp. 45-51

  2. Metástasis: aspectos biológicos de su desarrollo y avances terapéuticos

    II Reunión Científica en Biología Celular y Molecular: técnicas de microscopía, micromanipulación y análisis de imagen